STAAR Surgical Co
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $124.0M | $90.6M | $82.4M | $75.0M | $72.2M | — | $63.8M | $62.8M |
| Cost of Revenue | $32.4M | $26.3M | $24.1M | $26.2M | $21.9M | — | $19.5M | $20.4M |
| Gross Profit | $91.5M | $64.3M | $58.4M | $48.8M | $50.3M | — | $44.3M | $42.4M |
| Gross Margin | 73.8% | 70.9% | 70.8% | 65.1% | 69.7% | — | 69.4% | 67.5% |
| Operating Expenses | ||||||||
| Research & Development | $22.0M | $20.0M | $20.7M | $12.4M | $6.7M | — | $6.4M | $5.9M |
| SG&A Expense | $84.9M | $67.9M | $71.0M | $18.3M | $16.8M | — | $15.2M | $14.9M |
| Operating Income | $6.6M | $-3.6M | $-12.7M | $-8.0M | $700.0K | — | $-1.2M | $2.8M |
| Operating Margin | 5.3% | -4.0% | -15.4% | -10.7% | 1.0% | — | -1.9% | 4.4% |
| Interest Expense | — | $112.0K | $112.0K | $154.0K | $170.0K | — | $291.0K | $523.0K |
| Pretax Income | $6.6M | $-2.3M | $-12.4M | $-8.6M | $1.1M | — | $-519.0K | $2.7M |
| Income Tax Expense | $1.7M | $-157.0K | $-315.0K | $-253.0K | $716.0K | — | $1.2M | $1.4M |
| Net Income | $5.0M | $-2.1M | $-12.1M | $-8.4M | $398.0K | — | $-1.8M | $1.3M |
| Net Margin | 4.0% | -2.4% | -14.7% | -11.2% | 0.6% | — | -2.8% | 2.1% |
| EPS (Basic) | $0.12 | $-0.05 | $-0.30 | $-0.22 | $0.01 | — | $-0.05 | $0.04 |
| EPS (Diluted) | $0.11 | $-0.05 | $-0.30 | $-0.22 | $0.01 | — | $-0.05 | $0.04 |
| Shares Outstanding (Basic) | 42.6M | 41.0M | 40.3M | 38.1M | 36.7M | 36.6M | 36.3M | 35.4M |
| Shares Outstanding (Diluted) | 45.3M | 41.0M | 40.3M | 38.1M | 38.6M | 36.6M | 36.3M | 36.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |